Patent · US Expired

Antiviral methods using human rhinovirus receptor (ICAM-1)

US7132395B1 · kind B1 · utility

0Cited by

51References

19Claims

0Family size

Assignee

Bayer Pharmaceuticals Corporation · US

Inventors

Jeffrey Greve · Branford, US
Alan McClelland · Tervuren, BE
Gary Davis · Milford, US

Key dates

Filing date	Sep 30, 1994
Grant date	Nov 7, 2006
Priority date	—
Expiry date	May 30, 2015

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Method of inhibiting human rhinovirus (HRV) Infection by contacting said HRV with a polypeptide comprising a fragment of human rhinovirus major receptor (HRR), said fragment comprising the HRV binding site and being selected from a specific group consisting of HRR domains.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.